Effect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery disease

• Published in: Diagnostic pathology Vol. 10; no. 1; p. 102
• Main Authors: Liao, BiHong, Cheng, KeQi, Dong, ShaoHong, Liu, HuaDong, Xu, ZhengLei
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 16.07.2015; BioMed Central
• Subjects: Adult; Apolipoprotein A-I - genetics; Apolipoproteins; Coronary Artery Disease - blood; Coronary Artery Disease - genetics; Coronary heart disease; Female; Genes; Genetic aspects; Genetic polymorphisms; Genetic Predisposition to Disease - genetics; Genotype; Humans; Lipids; Lipids - blood; Male; Middle Aged; Odds Ratio; Physiological aspects; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Prevention; Risk Factors
• ISSN: 1746-1596; 1746-1596
• DOI: 10.1186/s13000-015-0328-7

The disorder of lipid metabolism and genetic predisposition are major risk factors for coronary artery disease (CAD). Variants in the apolipoprotein A1 (APOA1) gene play an important role in the regulation of lipids. The objective of the present study was to investigate the effect of two polymorphisms (-75 G/A and +83 C/T) of APOA1 on lipid profiles and the risk of CAD. A total number of 300 subjects with CAD and 300 age and sex matched healthy controls were enrolled for the study. Genotyping of the APOA1 was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) combined with gel electrophoresis, and then confirmed by direct sequencing. The frequencies of APOA1 -75 AA genotype [odds ratio (OR) =0.50, 95% confidence interval (CI) = 0.28, 0.88; P = 0.02] and APOA1 -75 A allele (OR =0.76, 95% CI = 0.59, 0.98; P = 0.04) were significantly lower in CAD than in controls. The APOA1 -75 A allele was significantly associated with increasing serum concentrations of ApoA1 and high-density lipoprotein cholesterol (HDL-C) (P < 0.001). The individuals with the APOA1 -75 A allele were likely to have a lower risk of CAD as a result of its effect on higher serum concentrations of ApoA1 and HDL-C.